loader
Please Wait
Applying Filters...

List of Drug Master Files (DMF) of Alpiny Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

Menu
$ API Ref.Price (USD/KG) : 7Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Granules India Limited

02 1IOL Chemicals and Pharmaceuticals

03 3Sanofi

04 1Seqens

05 8ANQIU LUAN PHARMACEUTICAL Co

06 1Abbott Laboratories

07 1Adare Pharma Solutions

08 1Anhui BBCA Likang pharmaceutical

09 1Atabay

10 1Aurobindo Pharma Limited

11 1Avantor Performance Materials

12 1BASF

13 1Bayer AG

14 1Beiersdorf AG

15 1Dinesh Pharmaceuticals

16 1Eli Lilly

17 3Farmson Pharmaceutical Gujarat Pvt Ltd

18 3HARTINGTON PHARMACEUTICAL

19 4Hebei Jiheng Pharmaceutical Co Ltd

20 1Industrias Monfel

21 1Jinzhou Jiutai Pharmaceutical

22 11Mallinckrodt Pharmaceuticals

23 2Meghmani Group

24 1Rhodia Organique SAS

25 3Sri Krishna Pharmaceuticals

26 1Yamamoto Corporation

27 3Zhejiang Kangle Pharmaceutical

28 1Zhejiang Ruibang Laboratories

29 18Blank

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 17722

Submission : 2004-09-22

Status : Active

Type : II

Granules India

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothIOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 37336

Submission : 2022-07-28

Status : Active

Type : II

IOL Chemicals

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 3142

Submission : 1978-02-01

Status : Inactive

Type : II

Sanofi Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

GDUFA

DMF Review : Complete

Rev. Date : 2013-04-10

Pay. Date : 2013-04-04

DMF Number : 17745

Submission : 2004-10-05

Status : Active

Type : II

Seqens Company Banner

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 18978

Submission : 2005-11-28

Status : Active

Type : II

Granules India

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 19972

Submission : 2006-11-16

Status : Active

Type : II

Granules India

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

GDUFA

DMF Review : Complete

Rev. Date : 2013-06-08

Pay. Date : 2012-11-29

DMF Number : 19804

Submission : 2006-09-28

Status : Active

Type : II

Granules India

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 5148

Submission : 1983-11-10

Status : Inactive

Type : II

Sanofi Company Banner

09

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 5048

Submission : 1983-07-22

Status : Inactive

Type : II

Sanofi Company Banner

10

Boulder Peptide 2024
Not Confirmed